| 1 |
Lee MH, Chang CL, Davies AR, et al. Cardiac dysfunction and N-terminal pro-B-type natriuretic peptide in exacerbations of chronic obstructive pulmonary disease[J]. Intern Med J, 2013, 43(5):595-598.
|
| 2 |
Buchan A, Bennett R, Coad A, et al. The role of cardiac biomarkers for predicting left ventricular dysfunction and cardiovascular mortality in acute exacerbations of COPD[J]. Open Heart, 2015, 2(1):e000052.
|
| 3 |
Adrish M, Nannaka VB, Cano EJ, et al. Significance of NT-pro-BNP in acute exacerbation of COPD patients without underlying left ventricular dysfunction[J]. Int J Chron Obstruct Pulmon Dis, 2017, (12):1183-1189.
|
| 4 |
Luchner A, von Haehling S, Holubarsch C, et al. Indications and Clinical Implications of the Use of the Cardiac Markers BNP and NT-proBNP[J]. Dtsch Med Wochenschr, 2017, 142(5):346-355.
|
| 5 |
McLellan J, Heneghan CJ, Perera R, et al. B-type natriuretic peptide-guided treatment for heart failure[J]. Cochrane Database Syst Rev, 2016, 12:CD008966.
|
| 6 |
Chin CW, Djohan AH, Lang CC, et al. The role of cardiac biochemical markers in aortic stenosis [J]. Biomarkers, 2016, 21(4):316-327.
|
| 7 |
Bajaj A, Rathor P, Sehgal V, et al. Prognostic Value of Biomarkers in Acute Non-massive Pulmonary Embolism: A Systematic Review and Meta-analysis[J]. Lung, 2015, 193(5):639-651.
|
| 8 |
Chen YR, Chen V, Hollander Z, et al. C-reactive protein and N-terminal prohormone brain natriuretic peptide as biomarkers in acute exacerbations of COPD leading to hospitalizations[J]. PLoS One, 2017, 12(3):e0174063.
|
| 9 |
Nishimura K, Nishimura T, Onishi K, et al. Changes in plasma levels of B-type natriuretic peptide with acute exacerbations of chronic obstructive pulmonary disease[J]. Int J Chron Obstruct Pulmon Dis, 2014, (9):155-156.
|
| 10 |
Pavasini R, Tavazzi G, Biscaglia S, et al. Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis[J]．Chron Respir Dis, 2017, 14(2):117-126.
|
| 11 |
Wu W, Wang H, Yu C, et al. Association of ADAMTS-7 levels with cardiac function in a rat model of acute myocard ial infarction[J]. Cell Physiol Biochem, 2016, 38(3):950-958.
|
| 12 |
Harbaum L, Hennigs JK, Baumann HJ, et al. N-Terminal ProBrain Natriuretic Peptide Is a Useful Prognostic Marker in Patients with Pre-Capillary Pulmonary Hypertension and Renal Insufficiency[J]. PLoS One, 2014, 9(4):e94263.
|
| 13 |
Adrish M, Nannaka VB, Cano EJ, et al. Significance of NT-pro-BNP in acute exacerbation of COPD patients without underlying left ventricular dysfunction[J]. Int J Chron Obstruct Pulmon Dis, 2017, (12):1183-1189.
|
| 14 |
Vallabhajosyula S, Haddad TM, Sundaragiri PR, et al. Role of B-Type natriuretic peptide in predicting in-hospital outcomes in acute exacerbation of chronic obstructive pulmonary disease with preserved left ventricular function: a 5-year retrospective analysis[J]. J Intensive Care Med, 2016, 885066616682232. doi: 10.1177/0885066616682232. |
| 15 |
付祥玲，任金林. 无创机械通气治疗慢性肺源性心脏病合并II型呼吸衰竭临床疗效研究[J]. 实用心脑血管病杂志，2016, 24(1):147-149.
|
| 16 |
Zhang J, Zhao G, Yu X, et al. Intravenous diuretic and vasodilator therapy reduce plasma brain natriuretic peptide levels in acute exacerbation of obstructive pulmonary disease[J]. Respirology, 2012, 17(4):715-720.
|
| 17 |
Palazzuoli A, Gallotta M, Quatrini I, et al. Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure[J]. Vasc Health Risk Manag, 2010, 6(6):411-418.
|
| 18 |
Abraham WT, Trupp RJ, Jarjoura D. Nesiritide in acute decompensated heart failure: a pooled analysis of randomized controlled trials[J]. Clin Cardiol, 2010, 33(8):484-489.
|
| 19 |
Miao ZL, Hou AJ, Zang HY, et al. Effects of recombinant human brain natriuretic peptide on the prognosis of patients with acute anterior myocardial infarction undergoing primary percutaneous coronary intervention: a prospective, multi-center, randomized clinical trial[J]. J Thorac Dis, 2017, 9(1):54-63.
|
| 20 |
Zhang S, Wang Z. Effect of recombinant human brain natriuretic peptide (rhBNP) versus nitroglycerin in patients with heart failure: A systematic review and meta-analysis[J]. Medicine (Baltimore), 2016, 95(44):e4757.
|
| 21 |
孙娟，丁毅鹏. 新活素治疗慢性肺源性心脏病合并心力衰竭临床观察[J]. 海南医学，2014, 25(22):3364-3365.
|
| 22 |
Bocchi EA, Moura LZ, Issa VS, et al. Effects of the Recombinant Form of the Natural Human B-type Natriuretic Peptide and Levosimendan on Pulmonary Hyperventilation and Chemosensivity in Heart Failure[J]. Cardiovasc Ther, 2013, 31(2):100-107.
|
| 23 |
Song Z, Zhao X, Liu M, et al. Recombinant human brain natriuretic peptide attenuates trauma-/hemorrhagic shock-induced acute lung injury through inhibiting oxidative stress and the NF-KB-dependent inflammatory/MMP-9 pathway[J]. Int J Exp Path, 2015, 96(6):406-413.
|